Translational Research Center for Gastrointestinal Diseases, Department of Chronic Diseases and Metabolism.
Department of Gastroenterology, Leuven University Hospitals Belgium.
Lancet Gastroenterol Hepatol. 2023 Apr;8(4):383-390. doi: 10.1016/S2468-1253(22)00435-6. Epub 2023 Jan 23.
Disorders of gut-brain interaction (DGBI) are frequently encountered in clinical practice, and recommendations for diagnosis and management are well established. In a large subset of patients, more than one DGBI diagnosis is present. This group of patients with more than one DGBI diagnosis have higher symptom severity and impact than patients with only one DGBI diagnosis, and the management approach is not well established for those with overlapping diagnoses. This Review aims to guide clinicians to understand, recognise, and manage overlapping DGBI by identifying causes and pitfalls of overlap conditions, and presenting potential practical approaches to diagnosis, treatment, and follow-up. Several clinical factors can contribute to finding overlapping DGBI, including the anatomical basis of the Rome diagnostic criteria, the potential confusion of symptom descriptors, and patients' biases towards higher symptom intensity ratings. Overlapping DGBI could also be caused by mechanistic factors such as pathophysiological mechanisms involving multiple gastrointestinal segments, and the effect of disorders in one segment on sensorimotor function in remote gastrointestinal parts, through neural or hormonal signalling. Key initial steps in the management of overlapping DGBI are detailed history taking, which can be facilitated using pictograms; carefully assessing the relative timing and cohesion of different symptoms; and recognising associated psychosocial dysfunction. Unnecessary technical investigations and complex combination treatment schedules should be avoided. Based on the identification of the dominant symptom pattern and putative underlying pathophysiological mechanisms, a single treatment modality should preferably be initiated, considering the efficacy spectrum of different therapies. Follow-up of the patient's condition allows the therapeutic approach to be adjusted as needed, while avoiding unnecessary additional technical investigations.
肠脑相互作用障碍(DGBI)在临床实践中经常遇到,其诊断和管理建议已经成熟。在很大一部分患者中,存在不止一种 DGBI 诊断。与仅有一种 DGBI 诊断的患者相比,这些存在多种 DGBI 诊断的患者的症状严重程度和影响更高,且重叠诊断患者的管理方法尚未确定。本综述旨在通过确定重叠疾病的原因和陷阱,并提出潜在的实用诊断、治疗和随访方法,指导临床医生了解、识别和管理重叠 DGBI。几个临床因素可以导致重叠 DGBI,包括罗马诊断标准的解剖学基础、症状描述符的潜在混淆以及患者对更高症状强度评分的偏见。重叠 DGBI 也可能是由机制因素引起的,例如涉及多个胃肠道节段的病理生理机制,以及一个节段的疾病对远程胃肠道部分的感觉运动功能的影响,通过神经或激素信号传递。重叠 DGBI 管理的关键初始步骤包括详细的病史采集,这可以通过使用象形图来促进;仔细评估不同症状的相对时间和一致性;并识别相关的心理社会功能障碍。应避免不必要的技术检查和复杂的联合治疗方案。基于对主要症状模式和潜在病理生理机制的识别,应优选启动单一治疗方式,同时考虑不同治疗方法的疗效谱。对患者病情的随访允许根据需要调整治疗方法,同时避免不必要的额外技术检查。